$12.95
0.463.68%
At close: -
$12.95
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Latest Cartesian Therapeutics Stock News | NASDAQ:RNAC | Benzinga
Get the latest news on Cartesian Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Cartesian Therapeutics performance
Categories: All
Friday, March 14, 2025
Thursday, March 13, 2025
Thursday, February 06, 2025
Tuesday, January 28, 2025
Monday, January 27, 2025
Monday, January 13, 2025
Thursday, December 19, 2024
Friday, December 13, 2024
Wednesday, December 04, 2024
Tuesday, December 03, 2024
Monday, November 25, 2024
Friday, November 08, 2024
Wednesday, October 16, 2024
Tuesday, October 15, 2024
Friday, September 13, 2024
Monday, September 09, 2024
Wednesday, September 04, 2024
Tuesday, September 03, 2024
Monday, August 12, 2024
Friday, August 09, 2024
Thursday, August 08, 2024
Tuesday, August 06, 2024
Monday, July 08, 2024
Friday, July 05, 2024
Wednesday, July 03, 2024
Tuesday, July 02, 2024
- Oppenheimer Downgrades Cartesian Therapeutics...
- Cartesian's Autoimmune Disorder Candidate Hits Primary Goal In Mid-Stage Study, Announces Equity Raise Of $130M
- Cartesian Therapeutics shares are trading low...
- Cartesian Therapeutics Has Entered Into A Pri...
- Cartesian Therapeutics Has Dosed The First Pa...
- Cartesian Therapeutics Announced Topline Resu...